ALFApump System Post Marketing Surveillance Registry (2011-AAR-004)
ALFApump System Post Marketing Surveillance Registry, In Support of the Following Indication: Automated Removal of Excess Peritoneal Fluid Into the Urinary Bladder in Patients With Cirrhosis or Malignancy, With Persistent or Refractory Ascites
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Dresden, Germany
- Uniklinik Dresden
-
Frankfurt, Germany
- Klinikum Der Johann Wolfgang Goethe Universitat
-
Homburg/Saar, Germany, 66421
- Universitatsklinikum des Saarlandes
-
Jena, Germany, 07747
- Universitatsklinikum Jena
-
Leipzig, Germany, 04129
- St Georg Klinik
-
Leipzig, Germany
- Universitatsklinikum Leipzig, AoR
-
Mannheim, Germany
- Medizinische Klinik, Universitätsmedizin Mannheim
-
Würzburg, Germany
- Uniklinik Würzburg
-
-
-
-
-
Barcelona, Spain
- Hosptial Universitari Vall d'Hebron
-
-
-
-
-
Bern, Switzerland, 3010
- Inselspital
-
Geneva, Switzerland
- University Clinic of Geneva (HUG)
-
-
-
-
-
London, United Kingdom
- The London Clinic, The liver centre
-
Newcastle on Tyne, United Kingdom
- Freeman Hospital Newcastle on Tyne
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Refractory or recurrent ascites and liver cirrhosis or malignancy
- written informed consent
Exclusion Criteria:
- < 18 years
- pregnant
- not able to use the Smart charger
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safety
Time Frame: 24 months
|
To monitor the safety of the ALFApump System
|
24 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
clinical performance
Time Frame: 24 months
|
To monitor clinical performance of the ALFApump System
|
24 months
|
|
clinical impact
Time Frame: 24 months
|
To monitor the clinical impact of the ALFApump System
|
24 months
|
|
usability
Time Frame: 1 month
|
To assess the usability of the ALFApump System
|
1 month
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Andrea De Gottardi, Privatdozent, University Hospital Inselspital, Berne
Publications and helpful links
General Publications
- Stirnimann G, Berg T, Spahr L, Zeuzem S, McPherson S, Lammert F, Storni F, Banz V, Babatz J, Vargas V, Geier A, Engelmann C, Herber A, Trepte C, Capel J, De Gottardi A. Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pump. Liver Int. 2022 Oct;42(10):2247-2259. doi: 10.1111/liv.15337. Epub 2022 Jul 25.
- Stirnimann G, Berg T, Spahr L, Zeuzem S, McPherson S, Lammert F, Storni F, Banz V, Babatz J, Vargas V, Geier A, Stallmach A, Engelmann C, Trepte C, Capel J, De Gottardi A. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis. Aliment Pharmacol Ther. 2017 Nov;46(10):981-991. doi: 10.1111/apt.14331. Epub 2017 Sep 21.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2011-AAR-004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.